Microangiopathy in temporal lobe epilepsy with diffusion MRI alterations and cognitive decline
Joan Liu1,2, Lawrence Binding1,3, Isha Puntambekar1
1Department of Clinical and Experimental Epilepsy, Department of Neuropathology, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Acta Neuropathologica
|October 8, 2024
Summary
Temporal lobe epilepsy (TLE) involves white matter microvascular damage, including arteriolosclerosis and reduced vessel size, potentially causing cognitive decline. These changes correlate with MRI findings and epilepsy duration.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- White matter microvascular alterations in temporal lobe epilepsy (TLE) may contribute to neurodegeneration and cognitive impairment.
- Understanding these changes is crucial for managing TLE-associated cognitive decline.
Purpose of the Study:
- To quantify microvascular changes, myelin, axonal, glial, and extracellular-matrix alterations in TLE white matter.
- To correlate these pathological findings with in vivo MRI diffusion measurements and cognitive function.
Main Methods:
- Analysis of surgical resections from 44 TLE patients and controls.
- Quantification of microvascular markers (collagen-4, PDGF-Rβ, SMA), myelin (MAG, PLP), and glial cells (Olig2, Iba1).
- Comparison with pre-operative MRI diffusion data and neuropsychological assessments.
Main Results:
- TLE showed increased arteriolosclerosis, reduced mean vascular size, and increased pericyte coverage compared to controls.
- Reduced myelin and increased glial numbers were observed, particularly in deep white matter.
- Microvascular changes correlated with MRI diffusivity, white matter abnormalities, and cognitive decline, especially increased perivascular space.
Conclusions:
- Acquired microangiopathic changes, including vascular sclerosis and altered small vessel function, are present in TLE.
- These pathological findings correlate with white matter diffusion MRI alterations.
- The observed microvascular changes may underlie cognitive decline in TLE patients.


